Kevin Stephens

Kevin Stephens serves as Department Head of the Medical Materials Division (MMD) at the Naval Medical Research Center, where he oversees the strategic acquisition of biomedical research tools, field-deployable diagnostics, and laboratory analytical systems critical to force health protection. In this leadership role, he directs the planning, solicitation, and award of contracts that enable cutting-edge medical innovation for U.S. Navy and Marine Corps personnel operating in austere environments. His procurement portfolio emphasizes rapid-response technologies, infectious disease detection platforms, and precision monitoring systems aligned with the Center’s mission to advance operational readiness through scientific advancement. Mr. Stephens maintains a primary contracting relationship with REES SCIENTIFIC CORPORATION, a trusted partner in the development and delivery of specialized biomedical instrumentation and diagnostic kits tailored for military field use. His procurement patterns reflect a preference for established vendors with proven technical capabilities in military-grade medical device development, biosafety compliance, and rapid prototyping. These relationships are characterized by long-term, performance-based contract structures that prioritize technical fidelity, reproducibility, and field validation under extreme conditions. Mr. Stephens does not utilize socioeconomic set-asides, with 100% of his acquisitions conducted under full and open competition. This reflects a mission-driven focus on technical merit and operational readiness over socioeconomic criteria, prioritizing capability and speed of delivery in support of urgent force health protection needs. His procurement activities center on advanced biomedical research and diagnostic technologies, with a strong emphasis on laboratory-based analytical systems, point-of-care diagnostics, and pathogen detection platforms. While NAICS codes are not formally tracked, his domain expertise spans high-complexity medical device procurement, in vitro diagnostic development, and biospecimen processing technologies—domains requiring rigorous validation, regulatory compliance, and deployment readiness in expeditionary settings.